PATENT CLAIM ANALYSIS

Application Number: 15777548
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["549", "069000"]

Abstract:
The present invention provides the pharmaceutical use of LPA1 antagonists, for example, α-halogenated thiophene compounds having a specific structure or pharmacologically acceptable salts thereof, as drugs for the treatment and/or prevention of NASH. A pharmaceutical composition for the treatment and/or prevention of NASH includes, as an active ingredient, an LPA1 antagonist, for example, a compound represented by the general formula (I): wherein R 1  is a hydrogen atom or a methoxy group, R 2  is a hydrogen atom or a C 1 -C 6  alkyl group, X is a halogen atom, and A is a group selected from the group consisting of groups: , or a pharmacologically acceptable salt thereof.

Claim (Index 4):
The pharmaceutical composition for the treatment and/or prevention of NASH, comprising an \u03b1-halogenated thiophene compound described in  claim 3  wherein R 1  in the general formula (I) is a hydrogen atom, or a pharmacologically acceptable salt thereof as an active ingredient.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.82609
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15974494', '14752623', '15736677', '15724002', '15522592']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7094743727789294
- 35 USC 102 Novelty (BERT): 0.5564164440303433
- Combined Prediction Score: 0.6941685799040709
- Mean Citation Score: 337.762312
- Max Citation Score: 431.25232
- Similarity Product: 301.4045274161816

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test